ClinicalTrials.gg
CompletedNCT06389643Updated Apr 29, 2024

Comparison of Safety and Efficacy of Four-Point Scleral Intraocular Lens Fixation and Yamane Techniques

An interventional study of Four-point scleral fixation of Akreos AO60 IOL and Sutureless scleral fixation of AcrySof MA60AC IOL with Yamane technique in Aphakia, sponsored by Military Institute od Medicine National Research Institute. Completed at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-29.

Sponsored by Military Institute od Medicine National Research Institute · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Mar 2021, registered Apr 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Comparison of safety and efficacy of two scleral fixation intraocular lens (IOL) methods of four-point scleral fixation ( Akreos AO60) and the Yamane technique (AcrySof MA60AC)

Read the detailed description

Purpose of the study is to compare two methods of scleral fixation of IOL: two-point fixation of AcrySof MA60AC IOL (Alcon) using Yamane technique and four-point fixation of the Akreos AO60 IOL (Bausch \& Lomb) using polypropylene suture. The investigators rated the BCVA, refractive outcomes, intraocular pressure, and also determined intra- and postoperative complications.

02

Conditions studied

  • Aphakia

Browse trials for

Keywords

  • scleral fixation IOL
  • sutureless fixation IOL
  • four-point scleral fixation
  • Yamane technique
  • aphakia
03

In context

Aphakia

69 studies on the registry are indexed under Aphakia; 6 are open to participants now.

This study's enrollment of 50 is below the median of 103 across 52 interventional studies indexed under Aphakia.

Browse Aphakia studies →

Lead sponsor

Military Institute od Medicine National Research Institute is the lead sponsor of 45 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • only adult men and women with aphakia without capsular support

Exclusion criteria

Exclusion Criteria:

  • Fuchs' dystrophy
  • corneal haze or scarring
  • history of corneal transplantation
  • astigmatism of more than 2,0D
  • clinically active uveitis
  • advanced glaucoma
  • macular diseases that affect visual acuity (age-related macular degeneration, diabetic maculopathy)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Four-point scleral fixation group

    Four-point scleral fixation group

    Procedure: Four-point scleral fixation of Akreos AO60 IOL

  • Active comparator
    Yamane technique group

    Yamane technique group

    Procedure: Sutureless scleral fixation of AcrySof MA60AC IOL with Yamane technique

Interventions

  • ProcedureFour-point scleral fixation of Akreos AO60 IOL

    Intrascleral tunnels were marked at a distance of 2 mm from the corneal limbus, 6 mm apart (4 in number) after retrobulbar anesthesia. Next corneal incisions were performed. An artificial lens was then implanted into the anterior chamber. The 6-0 polypropylene suture was introduced into the anterior chamber through openings in the cornea. The next stage was to perform a sclerotomy using a 30G needle. Then the needle was passed through the hole in the haptic and 6-0 polypropylene suture was inserted into the needle hole and guided outside. The other end of the suture, passed through the opening in the haptic, was placed in the lumen of the needle and carried out through another sclerotomy and then externalised. This maneuver was repeated with another haptics as well. Correct position of the IOL in the eye was achieved by pulling on the ends of the monofilament. The ends of sutures were trimmed and cauterized. The melted tips of the sutures were then fixed subconjunctivally.

  • ProcedureSutureless scleral fixation of AcrySof MA60AC IOL with Yamane technique

    The surgery was performed under retrobulbar anesthesia. The first step of the procedure was to mark the locations of the intrascleral tunnels (2 mm from the corneal limbus) and locate them at a distance of 180° from each other to prevent the lens from tilting in the eyeball. Openings in the cornea were done. Three-piece IOL was implanted into the anterior chamber. The first sclerotomy was performed through the conjunctiva using a 30G needle 2 mm from the limbus. One of the haptics was inserted into the needle lumen and then brought out. Same procedure was performed with another haptic at a distance of 180°. The next step was to perform cautery of the tips of the haptics, obtaining a 0.3 mm collar that prevents the risk of the haptic coming out of the tunnel and displacing the lens inside the eyeball. The tips of the haptics were finally gently inserted into the scleral canals and covered with conjunctiva.

06

What researchers measure

Primary outcomes

  1. BCVA

    The change of best- corrected visual acuity

    Time frame: before and 12 months after surgery

  2. RE

    Postoperative total refractive error

    Time frame: 12 months after surgery

  3. ECC

    corneal endothelial cell density

    Time frame: before and 12 months after surgery

Secondary outcomes

  1. Number of complications

    Rate of complications

    Time frame: from day 1 until 12 months after surgery

07

Study locations

1 site
  • Military Institute of Medicine - National Research Institute
    Warsaw, 04-141, Poland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06389643
Lead sponsor
Military Institute od Medicine National Research Institute
Responsible party
Sponsor
First posted
Apr 29, 2024
Start date
Mar 19, 2021
Primary completion
Sep 14, 2022
Completion
Sep 19, 2023
Last update
Apr 29, 2024

Study contacts

Natalia Blagun, MD
principal investigator · Military Institute of Medicine - National Research Institute

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion